DPLO - Diplomat Pharmacy, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5387.02M
Enterprise Value 31.03B
Trailing P/E N/A
Forward P/E 1-172.67
PEG Ratio (5 yr expected) 11.80
Price/Sales (ttm)0.07
Price/Book (mrq)0.84
Enterprise Value/Revenue 30.19
Enterprise Value/EBITDA 69.98

Trading Information

Stock Price History

Beta (3Y Monthly) 1.24
52-Week Change 3-76.31%
S&P500 52-Week Change 36.04%
52 Week High 322.82
52 Week Low 34.17
50-Day Moving Average 35.30
200-Day Moving Average 37.53

Share Statistics

Avg Vol (3 month) 3783.51k
Avg Vol (10 day) 3653.27k
Shares Outstanding 574.71M
Float 49.72M
% Held by Insiders 123.71%
% Held by Institutions 192.71%
Shares Short (Jun 28, 2019) 48.96M
Short Ratio (Jun 28, 2019) 410.02
Short % of Float (Jun 28, 2019) 418.47%
Short % of Shares Outstanding (Jun 28, 2019) 411.99%
Shares Short (prior month May 31, 2019) 48.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -5.85%
Operating Margin (ttm)0.58%

Management Effectiveness

Return on Assets (ttm)1.19%
Return on Equity (ttm)-52.17%

Income Statement

Revenue (ttm)5.41B
Revenue Per Share (ttm)72.71
Quarterly Revenue Growth (yoy)-6.40%
Gross Profit (ttm)376.01M
EBITDA 103.43M
Net Income Avi to Common (ttm)-316.12M
Diluted EPS (ttm)-4.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.74M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)638.8M
Total Debt/Equity (mrq)139.51
Current Ratio (mrq)1.00
Book Value Per Share (mrq)6.13

Cash Flow Statement

Operating Cash Flow (ttm)10.12M
Levered Free Cash Flow (ttm)-12.5M